封面
市場調查報告書
商品編碼
2051252

腸外營養市場:依營養類型、病患類型、應用、通路和地區分類

Parenteral Nutrition Market, By Nutrition Type, By Patient Type, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,腸外營養(靜態營養)市場規模將達到 48.398 億美元,到 2033 年將達到 74.717 億美元。預計從 2026 年到 2033 年,該市場將以 6.4% 的複合年成長率成長。

分析範圍 分析詳情
基準年 2025 市場規模(2026 年) 48.398億美元
效能數據 2020-2024 預測期 2026-2033
預測期(2026-2033 年)複合年成長率 6.40% 預計金額(2033 年) 74.717億美元

腸外營養(通常也稱為完全腸外營養)是一個醫學術語,指的是透過靜脈輸注特定形式的營養物質。這種治療的目標是改善或預防營養不良。腸外營養提供液態營養,包括碳水化合物、蛋白質、脂類、維生素、礦物質和電解質。有些人使用腸外營養來補充經腸營養是指透過插入胃或小腸的導管輸送營養物質),而有些人則單獨使用腸外營養。腸外營養適用於消化器官系統無法吸收或耐受足夠口服食物的患者。在醫院外進行的腸外營養稱為家庭腸外營養。家庭腸外營養可能需要持續數週至數月,在某些情況下,甚至需要終身進行。導管感染是腸外營養常見的嚴重併發症。腸外營養的其他短期併發症包括血栓、體液和礦物質失衡以及葡萄糖代謝紊亂。

市場動態:

近年來,由於導致營養不良的慢性疾病盛行率不斷上升,全球腸外營養市場經歷了顯著成長。腸外營養是治療方法,當患者無法經由口腔或經由腸道攝取營養時,可透過靜脈導管將營養物質直接輸送到血液中。它廣泛用於治療患有癌症、胃腸道疾病、肝病和其他慢性疾病的營養不良患者。此外,老年人口的不斷成長,由於消化器官系統功能受損,老年人更容易出現營養不良,這也推動了對腸外營養製劑需求的成長。許多市場相關人員正致力於開發創新的腸外營養解決方案,以滿足這些患者群體的治療需求。然而,腸外營養治療的高成本仍是其廣泛應用的主要挑戰。

本報告的主要特點

  • 本報告揭示了各個細分市場的潛在商機,並描述了該市場中一系列有吸引力的投資提案。
  • 此外,它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
  • 本節根據公司概況、產品系列、主要亮點、財務表現和策略等各種參數,對全球腸外營養市場的主要公司進行介紹。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
  • 《全球腸外營養市場》報告面向該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過分析全球腸外營養市場中使用的各種策略矩陣來促進決策。

目錄

第1章:分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 大型公司之間合作關係的增加
    • 缺乏對醫療保健、飲食和合理營養方面的知識
    • 先進腸外營養解決方案的出現
  • 主要亮點
  • 監管趨勢
  • 市場趨勢
  • 產品上市及核准
  • PEST分析
  • 波特五力分析
  • 流行病學
  • 大型公司的新投資
  • 價格分析
  • 企業合併、商業夥伴關係

第4章 全球腸外營養市場:依營養類型分類(2021-2033 年)

  • 碳水化合物
  • 脂質乳劑
  • 維生素和微量元素
  • 蛋白質
  • 其他(例如氨基酸)

第5章 全球腸外營養市場:依病患類型分類(2021-2033 年)

  • 嬰兒
  • 成人
  • 老年人

第6章 全球腸外營養市場:依應用領域分類(2021-2033年)

  • 糖尿病
  • 腎衰竭
  • 肌肉少症
  • 癌症
  • 其他(消化系統疾病、METABOLIC INC.症候群等)

第7章 全球腸外營養市場:依通路分類(2021-2033 年)

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第8章 全球腸外營養市場:按地區分類(2021-2033 年)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第9章 競爭情勢

  • 公司簡介
    • AbbVie Inc.
    • Danone
    • Fresenius Kabi AG
    • GENTAG, Inc.
    • GSK plc.
    • Nestle SA
    • Nutricia
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Sanofi
    • VIRIDIAN SA
  • 分析師意見

第10章

  • 參考
  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI4804

Parenteral Nutrition Market is estimated to be valued at USD 4,839.8 Mn in 2026 and is expected to reach USD 7,471.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 4,839.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.40% 2033 Value Projection: USD 7,471.7 Mn

Parenteral nutrition, often called total parenteral nutrition, is the medical term for infusing a specialized form of food through a vein (intravenously). The goal of the treatment is to correct or prevent malnutrition. Parenteral nutrition provides liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals and electrolytes. Some people use parenteral nutrition to supplement feeding through a tube placed into the stomach or small bowel (enteral nutrition), and others use it by itself. People whose digestive systems either can't absorb or can't tolerate adequate food eaten by mouth use parenteral nutrition. When used outside the hospital, intravenous feeding is called home parenteral nutrition. Using home parenteral nutrition may be necessary for weeks or months, or in some cases for life. Catheter infection is a common and serious complication of parenteral nutrition. Other potential short-term complications of parenteral nutrition include blood clots, fluid and mineral imbalances, and problems with blood sugar metabolism.

Market Dynamics:

The global parenteral nutrition market has been witnessing significant growth in the recent past owing to the rising prevalence of chronic diseases inducing malnutrition. Parenteral nutrition entails delivering nutrients directly into the bloodstream through an intravenous catheter when oral or enteral routes are not feasible. It finds wide application in treating malnourished patients suffering from cancer, gastrointestinal disorders, liver diseases, and other chronic conditions. Furthermore, the growing geriatric population who are more susceptible to malnutrition due to weak digestive system has also contributed to the rising demand for parenteral formulations. Various market players are engaged in developing innovative parenteral nutrition solutions to meet the treatment demands of such patient groups. However, high costs associated with parenteral feeding remains a major challenge for widespread adoption.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global parenteral nutrition market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include global parenteral nutrition market include AbbVie Inc., Danone, Fresenius Kabi AG, GENTAG, Inc., GSK plc., Nestle SA, Nutricia, Sun Pharmaceutical Industries Ltd, Pfizer Inc., Sanofi, Otsuka Holdings Co., Ltd., and Otsuka Holdings Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global parenteral nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global parenteral nutrition market.

Detailed Segmentation:

  • Global Parenteral Nutrition Market, By Nutrition Type (Revenue, USD Mn, 2021 - 2033)
  • Carbohydrates
  • Lipid Emulsion
  • Vitamins and Trace Minerals
  • Proteins
  • Others (Amino acids, etc.)
  • Global Parenteral Nutrition Market, By Patient Type (Revenue, USD Mn, 2021 - 2033)
  • Infants
  • Adults
  • Geriatric
  • Global Parenteral Nutrition Market, By Application (Revenue, USD Mn, 2021 - 2033)
  • Diabetes
  • Renal Failures
  • Obesity
  • Sarcopenia
  • Cancer
  • Others (Digestive disorders, Metabolic Syndromes, etc.)
  • Global Parenteral Nutrition Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Top Companies in the Global Parenteral Nutrition Market:
  • AbbVie Inc.
  • Danone
  • Fresenius Kabi AG
  • GENTAG, Inc.
  • GSK plc.
  • Nestle SA
  • Nutricia
  • Sun Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Sanofi
  • VIRIDIAN SA

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Nutrition Type
    • Market Snippet, By Patient Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing collaborations by key market players
    • Lack of awareness regarding healthcare, diet, and proper nutrition
    • Emergence of enhanced parenteral nutrition solutions
  • Key Highlights
  • Regulatory Scenario
  • Market Trends
  • Product Launch/Approval
  • PEST Analysis
  • PORTER's Analysis
  • Epidemiology
  • New Investments by Major Market Players
  • Pricing Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Parenteral Nutrition Market, By Nutrition Type, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Carbohydrates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Lipid Emulsion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Vitamins and Trace Minerals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Others (Amino acids, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

5. Global Parenteral Nutrition Market, By Patient Type, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Infants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global Parenteral Nutrition Market, By Application, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Renal Failures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Sarcopenia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Others (Digestive disorders, Metabolic Syndromes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

7. Global Parenteral Nutrition Market, By Distribution Channel, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

8. Global Parenteral Nutrition Market, By Region, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profile
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Danone
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Fresenius Kabi AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • GENTAG, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • GSK plc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Nestle SA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Nutricia
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sun Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • VIRIDIAN SA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us